Aethlon Medical
AEMD
19 hedge funds and large institutions have $1.21M invested in Aethlon Medical in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
0.06% more ownership
Funds ownership: 0.14% → 0.2% (+0.06%)
5% less funds holding
Funds holding: 20 → 19 (-1)
12% less capital invested
Capital invested by funds: $1.38M → $1.21M (-$172K)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$831K |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
+$279K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$82.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$18.3K |
| 5 |
HF
HRT Financial
New York
|
+$11.6K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$106K |
| 2 |
VF
Virtu Financial
New York
|
-$45.3K |
| 3 |
SCA
Sassicaia Capital Advisers
Jericho,
New York
|
-$31K |
| 4 |
Renaissance Technologies
New York
|
-$25.2K |
| 5 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$19.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Renaissance Technologies
New York
| – | -$25.2K | -366 | Closed |
|
|
SRL
27
Scientech Research LLC
Jersey City,
New Jersey
| – | -$19.4K | -282 | Closed |
|
|
IA
28
IFP Advisors
Tampa,
Florida
| – | -$9.38K | -136 | Closed |
|
AEMD Hedge Fund Activity: Q1 2025 in Review
19 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2025, worth a combined $1.21M — down 12% from $1.38M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of AEMD and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.
The largest buyer was Armistice Capital, opening a new position worth an estimated $831K. The largest seller was UBS Group, cutting an estimated $106K.
- 19 institutional investors held Aethlon Medical (AEMD) as of Q1 2025, down from 20 in Q4 2024.
- Funds reported $1.21M of Aethlon Medical stock for Q1 2025, down 12% quarter-over-quarter.
- 5 funds opened new Aethlon Medical positions in Q1 2025 and 6 closed out, a net change of -1 holder.
- The largest Aethlon Medical buyer in Q1 2025 was Armistice Capital, an estimated $831K added.
- The largest Aethlon Medical seller in Q1 2025 was UBS Group, an estimated $106K sold.
Based on aggregated 13F filings for Q1 2025.